Full Answer
How to contact Genentech?
Ask about possible side effects and any other medical questions related to your prescribed Genentech medicine. Call us at (800) 821-8590, Monday-Friday, 5am-5pm PT. Chat with us using our live chat feature, Monday-Friday, 5am-5pm PT. Email us by filling out this form.
What is the phone number for Genentech?
Call us at (877) 436-3683 or (877) GENENTECH, Monday-Friday, 6am-5pm PT. This service offers coverage support, patient assistance, and other useful information. Provides free medicine to patients without insurance coverage or who can't pay for their Genentech medicine. Provides additional resources and information.
How to report kadcyla side effects?
Report side effects for your Kadcyla prescription. Report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. Get help paying for your Kadcyla prescription. SUPPORT.
What is kadcyla used for?
KADCYLA is a prescription medicine used to treat HER2-positive breast cancer that has spread to other parts of the body (metastatic breast cancer) after prior treatment with trastuzumab (Herceptin) and a taxane. Prior treatment could have been for the initial treatment of breast cancer or for the treatment of cancer that had spread ...
How long after kadcyla can you use birth control?
Birth control should be used while you receive KADCYLA and for 7 months after your last dose of KADCYLA
How to report kdcyla exposure?
If you are exposed to KADCYLA during pregnancy or if you become pregnant within 7 months following your last dose of KADCYLA, you are encouraged to report KADCYLA exposure to Genentech by calling 1-888-835-2555.
What is the number to call Genentech?
Ask about possible side effects and any other medical questions related to your prescribed Genentech medicine. Call us at (800) 821-8590, Monday-Friday, 5am-5pm PT.
How to contact Genentech about Kadcyla?
You are encouraged to report side effects to Genentech and the FDA. You may contact Genentech by calling 1-888-835-2555. You may contact the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.
How to contact Kadcyla?
Get answers to your questions about prescribing Kadcyla. SUPPORT. Medicine Information Support. Medical information about Genentech medicines. Call us at (800) 821-8590, Monday-Friday, 5am-5pm PT. Request a Call Back.
What is the number for Genentech?
Genentech Patient Resource Center. Our center dedicated to getting patients and caregivers to the right resources. Call us at (877) 436-3683 or (877) GENENTECH, Monday-Friday, 6am-5pm PT. Genentech Access Solutions. This service offers your patients coverage support, assistance, and other useful information.
What is kadcyla used for?
KADCYLA ®, as a single agent, is indicated for the treatment of patients with HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination. Patients should have either: 1 Received prior therapy for metastatic disease, or 2 Developed disease recurrence during or within six months of completing adjuvant therapy.
Is Kadcyla a single agent?
KADCYLA ®, as a single agent, is indicated for the adjuvant treatment of patients with HER2-positive early breast cancer who have residual invasive disease after neoadjuvant taxane and trastuzumab-based treatment.
Can kadcyla cause death?
Withhold treatment for clinically significant decrease in left ventricular function. Embryo-Fetal Toxicity: Exposure to KADCYLA can result in embryo-fetal death or birth defects. Advise patients of these risks and the need for effective contraception.
What is kadcyla patient assistance?
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
What is Genentech Access to Care Foundation?
The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change.
What is kadcyla used for?
Kadcyla (ado-trastuzumab emtansine) is a member of the HER2 inhibitors drug class and is commonly used for Breast Cancer, and Breast Cancer - Metastatic.
Is Kadcyla valid with insurance?
Prices are for cash paying customers only and are not valid with insurance plans. This Kadcyla price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Does Kadcyla offer rebates?
Kadcyla Genentech Oncology Co-pay Assistance Program Rebate:Eligible commercially insured patients enrolled in the program may be entitled to a rebate for their out-of-pocket cost if they paid the provider directly for treatment; for additional information contact the program at 855-692-6729.
